Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00373178
Recruitment Status :
First Posted : September 7, 2006
Last Update Posted : November 2, 2012
Aristotle University Of Thessaloniki
University of Athens
Information provided by (Responsible Party):
Nikolaos Kadoglou, Aristotle University Of Thessaloniki
The aim of the present study is to investigate the influence of several anti-diabetic regimens (metformin,glitazone,sulfonylurea,glinidine) and diet on metabolic parameters in patients with recently diagnosed type 2 diabetes.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.